NCT03480854

The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative

Improving Quality and Value of Multiple Sclerosis Care at the Microsystem Level: The Multiple Sclerosis Continuous Quality Improvement (MSCQI) Collaborative

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 694 (actual)
• Sponsor: Dartmouth-Hitchcock Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To establish the first systems level continuous quality improvement (CQI) collaborative for multiple sclerosis (MS) in the United States, to conduct benchmarking analyses and assessments of geographic variation in MS care quality and value, and study the effect of CQI interventions on improvement of selected performance (quality) indicators.

Detailed description

This is a three year study which employed a step-wedge randomized design which exposed three of four participating centers to a healthcare QI intervention during the 3 year period. Each of the centers exposed to an intervention served as its own control during a baseline pre-intervention period during the first year of the study. The fourth site served as a longitudinal control for comparison to the other three centers exposed to a QI intervention.

Conditions

• Multiple Sclerosis

Interventions

Type	Name	Description
OTHER	Quality Improvement	Randomly selected sites will receive one of two system level improvement approaches; 1) patient centered specialty medical home certification 2) IHI Breakthrough Series improvement approach with professional improvement coaching.

Timeline

• Start date: 2017-07-01
• Primary completion: 2020-06-30
• Completion: 2020-12-31
• First posted: 2018-03-29
• Last updated: 2021-05-07

Locations

4 sites across 1 country: United States